Quaker Chemical Corp. (KWR) - 10-Q Summary for Period Ended September 30, 2025
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2025. Quaker Chemical Corporation (doing business as Quaker Houghton) is the global leader in industrial process fluids, serving steel, aluminum, automotive, aerospace, and metalworking industries across three reportable segments: Americas, EMEA, and Asia/Pacific. The company operates in over 25 countries.
Key Financial Metrics
| Metric | Q3 2025 | Q3 2024 | YTD 9M 2025 | YTD 9M 2024 |
|---|---|---|---|---|
| Net Sales | $493.8 million | $462.3 million | $1,420.2 million | $1,395.6 million |
| Gross Profit | $180.9 million | $172.5 million | $513.8 million | $529.8 million |
| Gross Margin | 36.6% | 37.3% | 36.2% | 38.0% |
| Operating Income | $46.6 million | $51.7 million | $21.8 million | $165.7 million |
| Net Income (Attributable to KWR) | $30.5 million | $32.3 million | $(23.2) million | $102.5 million |
| Diluted EPS | $1.75 | $1.81 | $(1.32) | $5.70 |
| Adjusted EBITDA | $82.9 million | $78.6 million | $227.4 million | $246.1 million |
| Cash from Operations (9M) | $89.9 million (vs. $141.5 million prior year) | |||
| Total Debt | $875.2 million (as of Sept 30, 2025) | |||
| Cash & Equivalents | $172.0 million (as of Sept 30, 2025) |
Material Changes vs. Prior Period
- Revenue Growth: Q3 2025 sales increased 7% year-over-year, driven by acquisitions (+5%), organic volume growth (+3%), and favorable currency (+1%), partially offset by price/mix declines (-2%).
- Significant Impairment: The YTD 2025 net loss is primarily due to a non-cash goodwill impairment charge of $88.8 million recorded in Q2 2025 related to the EMEA reporting unit. This charge was driven by soft end-market conditions, tariff uncertainty, and an increased cost of capital.
- Restructuring Costs: Restructuring and related charges increased significantly to $31.1 million for the nine months ended Sept 30, 2025, compared to $4.8 million in the prior year, as the company accelerates a global cost optimization program targeting $40 million in additional annualized savings.
- Acquisitions: The company completed the acquisition of Dipsol Chemicals (Japan) in April 2025 for a net purchase price of ~$155.5 million, along with smaller acquisitions of Natech (UK) and CSI (South Africa). These contributed approximately $41.5 million to YTD sales.
- Margin Compression: Gross margins declined to 36.6% in Q3 (from 37.3% prior year) due to higher raw material costs, manufacturing costs, and acquisition-related inventory step-up amortization.
Guidance, Outlook, and Risks
- Outlook: Management expects continued soft end-market conditions and uncertainty regarding tariffs, particularly in the Americas and EMEA. However, the company highlights new business wins and growth in the Asia/Pacific segment.
- Restructuring: The global cost and optimization program is expected to be substantially complete by the end of 2026. Total one-time cash costs are estimated at 1 to 1.5 times the annualized savings.
- Tax Legislation: The "One Big Beautiful Bill Act" (H.R. 1) signed in July 2025 includes changes to federal corporate tax provisions. Management does not expect provisions effective in 2025 to have a material impact, but is evaluating future provisions.
- Liquidity: The company maintains a $500 million revolving credit facility with approximately $273 million in unused capacity. Management believes existing cash and liquidity are sufficient to fund operations, dividends, and capital expenditures for the next 12 months.
- Risks: Key risks include global economic downturns, inflationary pressures on raw materials, supply chain constraints, foreign currency fluctuations, and the impact of tariffs and trade policies.
Investor Verification Checklist
- EMEA Impairment Details: Verify the specific assumptions used in the Q2 goodwill impairment test for the EMEA unit, particularly regarding the weighted average cost of capital (WACC) and projected EBITDA.
- Acquisition Integration: Monitor the integration progress and synergy realization of the Dipsol acquisition, which significantly impacts the Asia/Pacific segment.
- Restructuring Execution: Track the actual cash outflows and headcount reductions against the projected $40 million in annualized savings from the ongoing restructuring program.
- Tariff Impact: Assess the ongoing impact of tariff uncertainty on the Americas and EMEA segments, which management cites as a primary driver of soft demand.
- Debt Levels: Review the increase in total debt to $875.2 million and the utilization of the revolving credit facility to fund acquisitions.